The mycinamicins are 16-membered macrolide antibiotics produced by Micrornonospora griseorubida, which have strong antibacterial activity against Gram-positive bacteria1~5). In the course of search for new antibiotics from the culture nitrates of mycinamicin-producing strains, we have discovered four newminor componentsdesignated mycinamicins X (1), X' (2), XI (3) and XI' (4). From physico-chemical properties, spectroscopic data and chemical degradation studies, these compounds were shown to be analogs ofmycinamicins I (5) and II (6) , whose structures are different from compounds 5and 6at the C-ll position. In this paper, wedescribe the isolation and structural elucidation of these compounds. The culture nitrates (200ml) of mycinamicinproducing strains of M. griseorubida were extracted with CHC13 at pH 7.5. The organic layer contained mycinamicins.The aqueous layer wasadjusted to pH3.0 with 1n hydrochloric acid. After this solution was adsorbedon Diaion HP-20resin (100ml), the resin was washed with water, and then with 30% aq MeOH. The active componentswere eluted with 80%aq MeOH. Theeluate wasconcentrated in vacuo to give a crude powder.The crude residue waspurified bypreparative HPLC(YMC-gel ODS 1-40/64, 300mmx20mm i.d.) using 0.1m NaH2PO4-MeOH (6:4) and (5:5) as solvent system with detection on 220nm.Fractions (20 ml) were collected at a flow rate of 10ml/minute. Individual fractions were assayedby analytical HPLC. Each fraction wascollected and combined,and the Table 2 . 13C NMRchemical shifts (CD3OD; 6) for mycinamicins X (1), X' (2), XI (3), XI' (4), I (5) and II (6). to C-l 1. The physico-chemical properties and NMR spectral data of mycinamicin X' (2) were quite similar to those of compound1, which accounts for the existence of diastereoisomeric forms. This was confirmed by synthesis by treatment of 5 with 7V-acetyl-L-cysteine (5 equiv) and NaHCO3 (5 equiv) in 80%aq acetone at 50°C for 2 hours to give two products identical in all respects with 1 and 2. The molecular formula ofmycinamicin XI (3) was determined to be C42H70N2O16S based on its FAB-MS spectrum ((M+H)+, m/z 891) and elemental analysis (Calcd: C 55.49, H 8.14, N 3.08, S 3.51. Found: C 55.42, H 8.14, N 2.97, S 3.22).
The UVand IR spectral data suggested the presence of an a,/?-unsaturated lactone. In the FAB-MS spectrum of 3, the protonated molecular ion (m/z 891) appeared at 163 mass units higher than the corresponding ion of mycinamicin II (6) (m/z 728).
The *H NMRspectrum of 3 showed an iV-acetyl proton at SH 2.00 (3H, s) in addition to the protons of 6, except for the olefinic protons at C-10 and C-ll. By a comparison of the 13CNMR spectra between 3 and 6, it was found that the signal of the olefinic carbon (Sc 127.9 and 145.3) (5 equiv) and NaHCO3(5 equiv) in 80% aq acetone at 50°C for 2 hours to give two products identical in all respects with 3 and 4.
In conclusion, we have elucidated the structures of four newmacrolide antibiotics, mycinamicins X (1), X' (2), XI (3) and XI' (4) by spectroscopic comparison with mycinamicins and chemical derivation from mycinamicins. Mycinamicins X (1) and XI (3) exhibited antibacterial activity against Gram-positive bacteria. As shown in Table 3 , the antibacterial activities of compounds 1 and 3 were much less than those of5 and 6.
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